Skip to content

AF Septal pacing

AF Septal pacing - AF Septal pacing

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45568
Enrollment
10
Registered
2018-06-28
Start date
2018-04-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrilation palpitations

Interventions

After the patient has undergone the ablation procedure, there is a waiting time of half an hour. During this time we want to conduct the study. The patient then already has monitor catheters in the
ablation
atrial fibrillation
pulmonary vein.
septal

Sponsors

Medtronic B.V.
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: * Patient referred to the center to undergo ablation of the pulmonary vein using radiofrequency (initial AF ablation, or redo procedure). * In case of paroxysmal AF the right atrium should be dilated as indicated by > 29 ml mm2 or the left atrium should be dilated as indicated by > 34 ml mm2. * Patient is willing and able to cooperate with the study procedure . * Patient is willing and able to cooperate with the study procedure. * Patient is willing and able to sign provide the Informed Consent for their participation in the study.

Exclusion criteria

Exclusion criteria: * Patients under 18 years or over 80 years old. * Women who are currently pregnant or have a positive pregnancy test. * Patients with an implantable cardiac device Patients who already underwent an AF septal ablation procedure.

Design outcomes

Primary

MeasureTime frame
To regard pacing site stability, the number of electrodes that are successfully placed will be counted. For this purpose, the pacing threshold must be less than 10mA at a pulse width of 1ms and no ventricular capture should occur when stimulation occurs with twice the atrial pacing threshold.

Secondary

MeasureTime frame
To assess Localized Atrial Capture the following endpoints will be considered: *The number of AF episodes in which local capture is recorded during atrial septal stimulation in at least one of the electrode positions *The number of electrodes for which local capture is determined using pacing schemes with various pacing cycle lengths (PCL) for a duration of 10-30 seconds depending on when capture occurs, at the start of the scheme followed, if feasible, by slow pacing for 1.5 s at 180% AFCL, initiated by a single stimulus at 130% AFCL. *The spatial extend of capture (assessed from the atrial electrograms recorded from the multipolar right atrial catheter and the multipolar coronary sinus catheter) to obtain local atrial capture obtained with septal pacing of AF, will be assessed off-line after the study procedure. To assess whether AF termination can be obtained using a dual-stage septal pacing scheme, the surface ECG will be analyzed and the PCL and stimulation current used, will be noted to measure the number of subjects in which the pacing scheme successfully terminates the AF episode.

Countries

Hungary, Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)